Advertisement

Topics

NextCure, Inc. Company Profile

05:48 EST 10th December 2018 | BioPortfolio

NextCure is a biopharmaceutical company focused on discovering and developing next generation first-in-class immunotherapy-based biologics for cancer and other diseases. The company leverages its FIND-IOTM technology to discover, validate and build a proprietary pipeline of novel immunotherapy targets.


News Articles [24 Associated News Articles listed on BioPortfolio]

Eli Lilly Pushes Full Steam Ahead on Immuno-Oncology With NextCure Pact

Lilly is paying NextCure $25 million upfront. NextCure will be eligible for various development and commercial milestone payments, as well as royalties on any commercial products. In addition, Lilly i...

Lilly and NextCure pen immuno-oncology deal

Eli Lilly & Co. and NextCure Inc. partnered to discover and develop new immuno-oncology therapies utilizing NextCure’s FIND-IO (Functional, Integrated, NextCure Discovery in Immuno Oncology) platfor...

NextCure Closes $93 Million B Round Led by China Investors for IO Therapies

NextCure of Maryland closed a $93 million series B financing led by China investors Hillhouse Capital and Quan Capital. The financing will support NextCure's next-gen immunomedicines for cancer and ot...

Lilly and NextCure Announce Collaboration to Discover and Develop Novel Immuno-Oncology Medicines

INDIANAPOLIS and BELTSVILLE, Md., Nov. 5, 2018 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and NextCure, Inc. today announced a multi-year collaboration focused on the discovery and...

Eli Lilly Commits $40M to NextCure in Hunt for New Cancer Drugs

Eli Lilly hasn’t been shy about making deals to build up its cancer immunotherapy pipeline, and its latest one is with NextCure, a biotech whose technology finds molecular targets that drive an immu...

NextCure begins Phase I/II trial of NC318 for solid tumours

NextCure has started a Phase I/II clinical trial of NC318 for the treatment of patients with advanced or metastatic solid...Read More... The post NextCure begins Phase I/II trial of NC318 for solid tu...

NextCure closes $93mm Series B round

NextCure Inc. (immunotherapies) raised $93mm through its Series B round. Hillhouse Capital and Quan Capital led, and were joined by Bay City Capital, Surveyor Capital (Citadel), Ping An Ventures, Taih...

NextCure Hopes Its Novel Target Therapies Will Treat Patients Not Helped By PD-1/L1 Inhibition

Emerging Company Profile: Based on discovery research at Yale, NextCure hopes S15 and other novel targets will provide new inroads...    

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

NextCure, Inc.

NextCure is a biopharmaceutical company focused on discovering and developing next generation first-in-class immunotherapy-based biologics for cancer and other diseases. The compa...

More Information about "NextCure, Inc." on BioPortfolio

We have published hundreds of NextCure, Inc. news stories on BioPortfolio along with dozens of NextCure, Inc. Clinical Trials and PubMed Articles about NextCure, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NextCure, Inc. Companies in our database. You can also find out about relevant NextCure, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...


Corporate Database Quicklinks



Searches Linking to this Company Record